Global Neuroendocrine Tumor Drug Market 2017 - Research Report By Application, Type, Key Players, Region and Forecast to 2022

 Published Date : Feb-2018   |    Format :PDF |    Number of Pages : 119   |    Publisher : e-Market Research

This report studies Neuroendocrine Tumor Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Eisai
    Exelixis, Inc.
    Foresee Pharmaceuticals, LLC
    Hutchison MediPharma Limited
    Intezyne, Inc
    INVENT Pharmaceuticals, Inc.
    Ipsen S.A.
    Jiangsu Hengrui Medicine Co., Ltd.
    Karyopharm Therapeutics, Inc.
    Lexicon Pharmaceuticals, Inc.
    Midatech Pharma Plc .
    Millennium Pharmaceuticals, Inc.
    MolMed S.p.A.
    Northwest Biotherapeutics, Inc.
    Novartis AG
    OctreoPharm Sciences GmbH
    OXiGENE, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    mTOR protein inhibitors
    Tyrosine kinase 3 inhibitors
    Somatostatin receptor antagonists
    Growth hormone releasing factor antagonists
    Somatostatin receptor agonists
    Others

By Application, the market can be split into
    Hospital
    Clinic
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Neuroendocrine Tumor Drug Market Professional Survey Report 2017
1 Industry Overview of Neuroendocrine Tumor Drug
    1.1 Definition and Specifications of Neuroendocrine Tumor Drug
        1.1.1 Definition of Neuroendocrine Tumor Drug
        1.1.2 Specifications of Neuroendocrine Tumor Drug
    1.2 Classification of Neuroendocrine Tumor Drug
        1.2.1 mTOR protein inhibitors
        1.2.2 Tyrosine kinase 3 inhibitors
        1.2.3 Somatostatin receptor antagonists
        1.2.4 Growth hormone releasing factor antagonists
        1.2.5 Somatostatin receptor agonists
        1.2.6 Others
    1.3 Applications of Neuroendocrine Tumor Drug
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug
    2.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug
    2.4 Industry Chain Structure of Neuroendocrine Tumor Drug

3 Technical Data and Manufacturing Plants Analysis of Neuroendocrine Tumor Drug
    3.1 Capacity and Commercial Production Date of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016

4 Global Neuroendocrine Tumor Drug Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Neuroendocrine Tumor Drug Capacity and Growth Rate Analysis
        4.2.2 2016 Neuroendocrine Tumor Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Neuroendocrine Tumor Drug Sales and Growth Rate Analysis
        4.3.2 2016 Neuroendocrine Tumor Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Neuroendocrine Tumor Drug Sales Price
        4.4.2 2016 Neuroendocrine Tumor Drug Sales Price Analysis (Company Segment)

5 Neuroendocrine Tumor Drug Regional Market Analysis
    5.1 North America Neuroendocrine Tumor Drug Market Analysis
        5.1.1 North America Neuroendocrine Tumor Drug Market Overview
        5.1.2 North America 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.1.4 North America 2016 Neuroendocrine Tumor Drug Market Share Analysis
    5.2 China Neuroendocrine Tumor Drug Market Analysis
        5.2.1 China Neuroendocrine Tumor Drug Market Overview
        5.2.2 China 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.2.4 China 2016 Neuroendocrine Tumor Drug Market Share Analysis
    5.3 Europe Neuroendocrine Tumor Drug Market Analysis
        5.3.1 Europe Neuroendocrine Tumor Drug Market Overview
        5.3.2 Europe 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.3.4 Europe 2016 Neuroendocrine Tumor Drug Market Share Analysis
    5.4 Southeast Asia Neuroendocrine Tumor Drug Market Analysis
        5.4.1 Southeast Asia Neuroendocrine Tumor Drug Market Overview
        5.4.2 Southeast Asia 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.4.4 Southeast Asia 2016 Neuroendocrine Tumor Drug Market Share Analysis
    5.5 Japan Neuroendocrine Tumor Drug Market Analysis
        5.5.1 Japan Neuroendocrine Tumor Drug Market Overview
        5.5.2 Japan 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.5.4 Japan 2016 Neuroendocrine Tumor Drug Market Share Analysis
    5.6 India Neuroendocrine Tumor Drug Market Analysis
        5.6.1 India Neuroendocrine Tumor Drug Market Overview
        5.6.2 India 2012-2017E Neuroendocrine Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Neuroendocrine Tumor Drug Sales Price Analysis
        5.6.4 India 2016 Neuroendocrine Tumor Drug Market Share Analysis

6 Global 2012-2017E Neuroendocrine Tumor Drug Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Neuroendocrine Tumor Drug Sales by Type
    6.2 Different Types of Neuroendocrine Tumor Drug Product Interview Price Analysis
    6.3 Different Types of Neuroendocrine Tumor Drug Product Driving Factors Analysis
        6.3.1 mTOR protein inhibitors of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        6.3.2 Tyrosine kinase 3 inhibitors of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        6.3.3 Somatostatin receptor antagonists of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        6.3.4 Growth hormone releasing factor antagonists of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        6.3.5 Somatostatin receptor agonists of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        6.3.6 Others of Neuroendocrine Tumor Drug Growth Driving Factor Analysis

7 Global 2012-2017E Neuroendocrine Tumor Drug Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Neuroendocrine Tumor Drug Consumption by Application
    7.2 Different Application of Neuroendocrine Tumor Drug Product Interview Price Analysis
    7.3 Different Application of Neuroendocrine Tumor Drug Product Driving Factors Analysis
        7.3.1 Hospital of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        7.3.2 Clinic of Neuroendocrine Tumor Drug Growth Driving Factor Analysis
        7.3.3 Others of Neuroendocrine Tumor Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Neuroendocrine Tumor Drug
    8.1 Eisai
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Eisai 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Eisai 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.2 Exelixis, Inc.
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Exelixis, Inc. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Exelixis, Inc. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.3 Foresee Pharmaceuticals, LLC
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Foresee Pharmaceuticals, LLC 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Foresee Pharmaceuticals, LLC 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.4 Hutchison MediPharma Limited
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Hutchison MediPharma Limited 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Hutchison MediPharma Limited 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.5 Intezyne, Inc
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Intezyne, Inc 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Intezyne, Inc 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.6 INVENT Pharmaceuticals, Inc.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 INVENT Pharmaceuticals, Inc. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 INVENT Pharmaceuticals, Inc. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.7 Ipsen S.A.
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Ipsen S.A. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Ipsen S.A. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.8 Jiangsu Hengrui Medicine Co., Ltd.
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Jiangsu Hengrui Medicine Co., Ltd. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Jiangsu Hengrui Medicine Co., Ltd. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.9 Karyopharm Therapeutics, Inc.
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Karyopharm Therapeutics, Inc. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Karyopharm Therapeutics, Inc. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.10 Lexicon Pharmaceuticals, Inc.
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Lexicon Pharmaceuticals, Inc. 2016 Neuroendocrine Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Lexicon Pharmaceuticals, Inc. 2016 Neuroendocrine Tumor Drug Business Region Distribution Analysis
    8.11 Midatech Pharma Plc .
    8.12 Millennium Pharmaceuticals, Inc.
    8.13 MolMed S.p.A.
    8.14 Northwest Biotherapeutics, Inc.
    8.15 Novartis AG
    8.16 OctreoPharm Sciences GmbH
    8.17 OXiGENE, Inc.

9 Development Trend of Analysis of Neuroendocrine Tumor Drug Market
    9.1 Global Neuroendocrine Tumor Drug Market Trend Analysis
        9.1.1 Global 2017-2022 Neuroendocrine Tumor Drug Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Neuroendocrine Tumor Drug Sales Price Forecast
    9.2 Neuroendocrine Tumor Drug Regional Market Trend
        9.2.1 North America 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
        9.2.2 China 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
        9.2.3 Europe 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
        9.2.5 Japan 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
        9.2.6 India 2017-2022 Neuroendocrine Tumor Drug Consumption Forecast
    9.3 Neuroendocrine Tumor Drug Market Trend (Product Type)
    9.4 Neuroendocrine Tumor Drug Market Trend (Application)

10 Neuroendocrine Tumor Drug Marketing Type Analysis
    10.1 Neuroendocrine Tumor Drug Regional Marketing Type Analysis
    10.2 Neuroendocrine Tumor Drug International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Neuroendocrine Tumor Drug by Region
    10.4 Neuroendocrine Tumor Drug Supply Chain Analysis

11 Consumers Analysis of Neuroendocrine Tumor Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Neuroendocrine Tumor Drug Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures
    Figure Picture of Neuroendocrine Tumor Drug
    Table Product Specifications of Neuroendocrine Tumor Drug
    Table Classification of Neuroendocrine Tumor Drug
    Figure Global Production Market Share of Neuroendocrine Tumor Drug by Type in 2016
    Figure mTOR protein inhibitors Picture
    Table Major Manufacturers of mTOR protein inhibitors
    Figure Tyrosine kinase 3 inhibitors Picture
    Table Major Manufacturers of Tyrosine kinase 3 inhibitors
    Figure Somatostatin receptor antagonists Picture
    Table Major Manufacturers of Somatostatin receptor antagonists
    Figure Growth hormone releasing factor antagonists Picture
    Table Major Manufacturers of Growth hormone releasing factor antagonists
    Figure Somatostatin receptor agonists Picture
    Table Major Manufacturers of Somatostatin receptor agonists
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Neuroendocrine Tumor Drug
    Figure Global Consumption Volume Market Share of Neuroendocrine Tumor Drug by Application in 2016
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Neuroendocrine Tumor Drug by Regions
    Figure North America Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Figure China Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Figure Europe Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Figure Japan Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Figure India Neuroendocrine Tumor Drug Market Size (Million USD) (2012-2022)
    Table Neuroendocrine Tumor Drug Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug in 2016
    Figure Manufacturing Process Analysis of Neuroendocrine Tumor Drug
    Figure Industry Chain Structure of Neuroendocrine Tumor Drug
    Table Capacity and Commercial Production Date of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Neuroendocrine Tumor Drug Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Neuroendocrine Tumor Drug 2012-2017
    Figure Global 2012-2017E Neuroendocrine Tumor Drug Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Neuroendocrine Tumor Drug Market Size (Value) and Growth Rate
    Table 2012-2017E Global Neuroendocrine Tumor Drug Capacity and Growth Rate
    Table 2016 Global Neuroendocrine Tumor Drug Capacity (K Pcs) List (Company Segment)
    Table 2012-2017E Global Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate
    Table 2016 Global Neuroendocrine Tumor Drug Sales (K Pcs) List (Company Segment)
    Table 2012-2017E Global Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Table 2016 Global Neuroendocrine Tumor Drug Sales Price (USD/Pcs) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E 
    Figure North America 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Figure North America 2016 Neuroendocrine Tumor Drug Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E 
    Figure China 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs) 
    Figure China 2016 Neuroendocrine Tumor Drug Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E
    Figure Europe 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Figure Europe 2016 Neuroendocrine Tumor Drug Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E
    Figure Southeast Asia 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Figure Southeast Asia 2016 Neuroendocrine Tumor Drug Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E
    Figure Japan 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Figure Japan 2016 Neuroendocrine Tumor Drug Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Pcs) of Neuroendocrine Tumor Drug 2012-2017E
    Figure India 2012-2017E Neuroendocrine Tumor Drug Sales Price (USD/Pcs)
    Figure India 2016 Neuroendocrine Tumor Drug Sales Market Share
    Table Global 2012-2017E Neuroendocrine Tumor Drug Sales (K Pcs) by Type
    Table Different Types Neuroendocrine Tumor Drug Product Interview Price
    Table Global 2012-2017E Neuroendocrine Tumor Drug Sales (K Pcs) by Application
    Table Different Application Neuroendocrine Tumor Drug Product Interview Price
    Table Eisai Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Eisai Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Eisai Neuroendocrine Tumor Drug Business Region Distribution
    Table Exelixis, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Exelixis, Inc. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Exelixis, Inc. Neuroendocrine Tumor Drug Business Region Distribution
    Table Foresee Pharmaceuticals, LLC Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Business Region Distribution
    Table Hutchison MediPharma Limited Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Business Region Distribution
    Table Intezyne, Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Intezyne, Inc Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Intezyne, Inc Neuroendocrine Tumor Drug Business Region Distribution
    Table INVENT Pharmaceuticals, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Business Region Distribution
    Table Ipsen S.A. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Ipsen S.A. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Ipsen S.A. Neuroendocrine Tumor Drug Business Region Distribution
    Table Jiangsu Hengrui Medicine Co., Ltd. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Business Region Distribution
    Table Karyopharm Therapeutics, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Business Region Distribution
    Table Lexicon Pharmaceuticals, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Business Region Distribution
    Table Midatech Pharma Plc . Information List
    Table Millennium Pharmaceuticals, Inc. Information List
    Table MolMed S.p.A. Information List
    Table Northwest Biotherapeutics, Inc. Information List
    Table Novartis AG Information List
    Table OctreoPharm Sciences GmbH Information List
    Table OXiGENE, Inc. Information List
    Figure Global 2017-2022 Neuroendocrine Tumor Drug Market Size (K Pcs) and Growth Rate Forecast
    Figure Global 2017-2022 Neuroendocrine Tumor Drug Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Forecast
    Figure North America 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure China 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Europe 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Japan 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure India 2017-2022 Neuroendocrine Tumor Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Table Global Sales Volume (K Pcs) of Neuroendocrine Tumor Drug by Type 2017-2022
    Table Global Consumption Volume (K Pcs) of Neuroendocrine Tumor Drug by Application 2017-2022
    Table Traders or Distributors with Contact Information of Neuroendocrine Tumor Drug by Region